About Aryeh Pharmaceuticals

Driven to cure. Empowered to deliver. Committed to access and affordability.

Founded in New Jersey, Aryeh is purpose-built to transform the United States generics market, restoring trust, ensuring quality, and expanding access to essential medicines where innovation meets impact.

Why Aryeh, Why Now

Because Access Deserves a Stronger Foundation

In the United States, 9 out of 10 prescriptions are generic, yet shortages, recalls, and price erosion remain common. Aryeh was created to change that.

Aryeh is designed for the United States with a bold, values-driven mission: restore trust, ensure quality, and strengthen patient access.

VISION & MISSION

The Aryeh Promise: Vision. Mission. Mindset

Our Vision

To be a bold, transformative force in generics, delivering life-saving therapies that are accessible, affordable, and uncompromising in quality.

Mission

To build a purpose-driven generics platform that combines innovation, regulatory excellence, and strategic partnerships to expand access to critical medicines and improve patient outcomes, with a focus on the United States.

Mindset

We move with courage. We lead with integrity. We deliver with purpose, because healthcare access should never be a privilege.

BDR Infrastructure

Global Strength, United States Precision

Since 2003, BDR Pharma has pioneered accessible healthcare in 30+ countries. Aryeh builds on this legacy with a focused U.S. model, combining proven innovation, integrated excellence, and global reach

Proven Innovation

First-to-market formulations and advanced drug delivery systems
Proprietary IPR portfolio and deep technical expertise
Success in developing high-impact, complex generics

Integrated Excellence

Many manufacturing & development facilities (APIs to finished formulations)
Backward integration ensuring cost, quality & supply reliability
Many R&D specialists driving complex generics innovation

Global Reach

Workforce of many professionals worldwide
Regulatory approvals across the United States., EU, and key emerging markets
Strong track record of product launches in niche, high-growth categories

FACILITIES OVERVIEW

Manufacturing Excellence Through Proven Infrastructure

Building on BDR’s robust infrastructure, Aryeh harnesses world-class facilities designed for consistent quality, regulatory compliance, and supply reliability, ensuring every product meets the highest global standards.

API Manufacturing

Padra, Vadodara: General & Oncology API blocks with advanced synthesis
Surat Facility: Dedicated API plant with backward integration for cost and quality assurance
Supply Chain Security: Vertical integration ensures reliable raw material supply and continuity

R&D & Product Development

Baska, Vadodara: Injection & oral solid dosage (OSD) development facilities
Innovation Team: Specialized R&D professionals advancing complex formulations
Regulatory Expertise: Bioequivalence studies & clinical trial capabilities for FDA submissions

Specialized Manufacturing

Hyderabad: Advanced pellets facility for controlled-release formulations
Complex Generics Focus: Expertise in high-barrier, differentiated molecules
Quality Systems: Full GMP compliance aligned with FDA gold standards

12+

Years of experience

STRATEGIC ALLIANCES

Partnerships Driving Sustainable Growth

Aryeh collaborates with global partners to expand capabilities, accelerate United States market entry, and deliver essential medicines with reliability and impact.

Innovation for Accessibility – In-house development, in-licensing, and strategic sourcing to ensure essential medicines reach patients where they’re needed most.
Market Acceleration – Purpose-driven partnerships that enable rapid U.S. entry and sustainable portfolio expansion
Integrated Advantage – Technology-enabled vertical integration ensuring consistent quality, cost efficiency, and supply reliability.

Leadership Excellence

Proven Leadership, Shared Vision

Aryeh’s leadership team blends decades of global expertise with a focused U.S. strategy, driving innovation, regulatory excellence, and market impact.

Deep Experience across geographies, therapeutic areas, and regulatory landscapes.

Transformational Impact through innovation, scale, and operational excellence.

Shared Vision for building world-class generics with patient access at the core.

Unwavering Commitment to trust, integrity, and lasting market transformation.

Join Our Mission

Partner with Aryeh to redefine generics access

Together, we can close gaps, expand availability, and ensure that essential medicines reach patients who need them most.

Let’s Collaborate